BlackRock’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.4M Sell
9,345,268
-33,193
-0.4% -$113K ﹤0.01% 2904
2025
Q4
$30.5M Buy
9,378,461
+274,595
+3% +$924K ﹤0.01% 2831
2025
Q3
$26.1M Sell
9,103,866
-590,228
-6% -$1.51M ﹤0.01% 2922
2025
Q2
$23.4M Buy
9,694,094
+145,261
+2% +$305K ﹤0.01% 2925
2025
Q1
$21.1M Sell
9,548,833
-229,091
-2% -$905K ﹤0.01% 2898
2024
Q4
$53.3M Sell
9,777,924
-698,159
-7% -$4.49M ﹤0.01% 2415
2024
Q3
$87.1M Buy
10,476,083
+747,124
+8% +$6.46M ﹤0.01% 2167
2024
Q2
$69.7M Buy
9,728,959
+3,314,335
+52% +$28.6M ﹤0.01% 2233
2024
Q1
$55.6M Sell
6,414,624
-67,044
-1% -$454K ﹤0.01% 2379
2023
Q4
$42.5M Buy
6,481,668
+554,360
+9% +$3.58M ﹤0.01% 2581
2023
Q3
$59.3M Buy
5,927,308
+181,493
+3% +$1.99M ﹤0.01% 2306
2023
Q2
$71.4M Sell
5,745,815
-154,100
-3% -$2.08M ﹤0.01% 2274
2023
Q1
$82.7M Buy
5,899,915
+126,007
+2% +$1.81M ﹤0.01% 2135
2022
Q4
$82.6M Buy
5,773,908
+78,397
+1% +$1.23M ﹤0.01% 2127
2022
Q3
$145M Sell
5,695,511
-114,829
-2% -$2.88M 0.01% 1710
2022
Q2
$165M Sell
5,810,340
-171,554
-3% -$5.43M 0.01% 1668
2022
Q1
$211M Sell
5,981,894
-71,153
-1% -$2.39M 0.01% 1637
2021
Q4
$254M Buy
6,053,047
+1,420,288
+31% +$57.5M 0.01% 1565
2021
Q3
$227M Buy
4,632,759
+700,552
+18% +$34.2M 0.01% 1621
2021
Q2
$164M Buy
3,932,207
+708,029
+22% +$27.4M ﹤0.01% 1923
2021
Q1
$115M Buy
3,224,178
+1,053,615
+49% +$34.9M ﹤0.01% 2111
2020
Q4
$60.9M Buy
+2,170,563
New +$60.4M ﹤0.01% 2362

Other funds holding MRVI